- NMPA approved Zongertinib for marketing conditionally
09/03 - Agenda of 15th CIMDR-Medical Device Innovation Forum08/12
- China-EU exchange on cosmetics regulatory system held in Bei...07/23
- Announcement of the National Medical Products Administration...07/18
- Guideline for Study on Manufacturing Process of Compound Pre...07/15
- Guideline for Quality Study of New Traditional Chinese Medic...07/10
International Cooperation- NMPA Elected as a Member of the ICH Management Committee10/29
- NMPA Issued Announcement on Releasing M4: Common Technical D...10/29
- NMPA Released Announcement on the Application of 13 ICH Guid...10/29
- NMPA Released Announcement on the Application of 15 ICH Guid...10/29
- Announcement of NMPA on Applying 11 ICH Guidelines Including...10/29
- Announcement of NMPA on Recommended Application of 4 ICH Gui...10/29
- Technical Requirements for Registration Application at Pilot...12/20
- Common problems and technical requirements of replication ...12/20
- Technical Guideline for Quality Control of Polysaccharide...12/20
- Technical Guideline on CMC Studies and Changes of Biological...12/20
- Dossier Requirements for Drug Marketing Authorization Applic...12/20
- Technical Guidelines for Studies on Pharmaceutical Changes o...12/20
